Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Tesfay Abreha, Bereket Alemayehu, Ashenafi Assefa, Ghulam Rahim Awab, J Kevin Baird, Beay Bezabih, Phaik Yeong Cheah, Nicholas P Day, Angela Devine, Mehul Dorda, Arjen M Dondorp, Samuel Girma, Tinh Hien Tran, Daddi Jima, Moges Kassa, Amha Kebende, Naw Htee Khu, Toby Leslie, Benedikt Ley, Yoel Lubell Show all
BMC Infectious Diseases | BIOMED CENTRAL LTD | Published : 2015
Awarded by Wellcome Trust
Awarded by UK Department for International Development Global health trials scheme
Awarded by Bill and Melinda Gates foundation
This work is supported by The Wellcome Trust, the UK Medical Research Council (MRC) and the UK Department for International Development Global health trials scheme [grant number MR/K007424/1], the Wellcome Trust (Senior Fellowship in Clinical Science to RNP 091625) and a grant from the Bill and Melinda Gates foundation [Global Health Grant number OPP1054404].